End Timeline News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from End timeline. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In End Timeline Today - Breaking & Trending Today

China's NMPA accepts Legend Biotech's NDA for cilta-cel - Pharmaceutical Business review

Cilta-cel is a BCMA-directed and genetically modified autologous T-cell immunotherapy that involves reprogramming a patient’s own T-cells with a transgene encoding a chimeric antigen receptor (CAR), which detects ....

Menu Hover , Subchild Level Menu Hover , Child Level Menu Hover , End Third Level , Bend Article , End Timeline ,

Vistagen agrees to acquire Pherin Pharmaceuticals

Vistagen has signed a definitive agreement for the acquisition of clinical-stage drug development firm Pherin Pharmaceuticals. ....

Shawn Singh , Pherin Pharmaceuticals , Robina Weermeijer , Menu Hover , Subchild Level Menu Hover , Child Level Menu Hover , End Third Level , Bend Article , End Timeline ,

FDA grants fast track designation for Kintara's breast cancer therapy

The US FDA has granted fast track designation (FTD) for Kintara Therapeutics’ REM-001, to treat cutaneous metastatic breast cancer (CMBC). ....

Menu Hover , Subchild Level Menu Hover , Child Level Menu Hover , End Third Level , Bend Article , End Timeline ,

Everest regulatory updates in Taiwan, South Korea for Nefecon

The regulatory authorities in Taiwan and South Korea have granted fast-tracked approval process for Everest Medicines’ Nefecon. ....

Menu Hover , Subchild Level Menu Hover , Child Level Menu Hover , End Third Level , Bend Article , End Timeline ,

SRI, Amylyx Pharmaceuticals partner to identify ALS drug candidates

SRI and Amylyx have joined forces to develop new drug candidates to treat amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. ....

Menu Hover , Subchild Level Menu Hover , Child Level Menu Hover , End Third Level , Bend Article , End Timeline ,